| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.34T | 1.71T | 1.08T | 1.28T | 1.53T |
| Gross Profit | 1.01T | 569.43B | -52.35B | 126.66B | 413.97B |
| EBITDA | 1.18T | 767.76B | 51.11B | 274.54B | 645.95B |
| Net Income | 554.49B | 272.31B | -243.73B | -138.14B | 105.92B |
Balance Sheet | |||||
| Total Assets | 3.69T | 2.92T | 2.86T | 2.97T | 3.07T |
| Cash, Cash Equivalents and Short-Term Investments | 470.71B | 167.93B | 187.59B | 261.35B | 469.81B |
| Total Debt | 1.25T | 999.52B | 1.29T | 1.27T | 1.25T |
| Total Liabilities | 2.29T | 2.18T | 2.42T | 2.32T | 2.27T |
| Stockholders Equity | 1.40T | 737.57B | 449.63B | 658.07B | 793.86B |
Cash Flow | |||||
| Free Cash Flow | 335.48B | 252.57B | -109.33B | -167.28B | 151.58B |
| Operating Cash Flow | 616.54B | 476.42B | 195.11B | 339.10B | 549.13B |
| Investing Cash Flow | -221.51B | -173.01B | -274.85B | -498.56B | -400.30B |
| Financing Cash Flow | -96.07B | -322.68B | 3.24B | -50.79B | -93.28B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥366.51B | 16.87 | ― | 2.04% | -8.82% | 18.33% | |
74 Outperform | ¥1.28T | 33.22 | 15.75% | 1.08% | 18.84% | 42.10% | |
70 Outperform | ¥42.36T | 76.78 | ― | ― | 36.99% | 102.67% | |
68 Neutral | ¥438.96B | 35.25 | 5.63% | 2.35% | -3.24% | -36.64% | |
66 Neutral | ¥5.93T | 92.50 | 7.72% | 0.40% | 12.66% | 89.12% | |
64 Neutral | ¥7.30T | 38.22 | ― | 1.41% | 13.61% | 17.01% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |